Medical Innovation Exchange

Merck KGaA hands over IL-12-targeting cancer med to PDS Biotech in $121M deal

https://www.fiercebiotech.com/biotech/merck-kgaa-hands-over-il-12-targeting-cancer-med-pds-biotech-121-million-deal

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!